Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Balks At Proposal For $4 Billion Annual Device Sector Charge

This article was originally published in The Gray Sheet

Executive Summary

The health reform debate moved closer to home for device makers last week, when details of Senate Finance Committee Chair Max Baucus' long-awaited proposal surfaced containing a $4 billion a year device manufacturer fee

You may also be interested in...



Sen. Baucus, Key Architect Of Device Tax, Health Reform, To Retire In 2014

Sen. Max Baucus, D-Mont., chairman of the powerful Senate Finance Committee, and one of the key architects of the Affordable Care Act and device tax, says he will serve out his term, but not seek re-election in November 2014.

Device Firms Dig In Against Baucus Fee, Despite Class I, Revenue Exceptions

The device industry lobbying machine has accelerated in opposition to Sen. Max Baucus' plan for a $40 billion fee on manufacturers in the lead up to Finance Committee health reform mark-up sessions this week

Device Firms Dig In Against Baucus Fee, Despite Class I, Revenue Exceptions

The device industry lobbying machine has accelerated in opposition to Sen. Max Baucus' plan for a $40 billion fee on manufacturers in the lead up to Finance Committee health reform mark-up sessions this week

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel